Pregnant women with rheumatic disease 'appeared to cope' wit
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Patients with rheumatic diseases who were pregnant at the time of developing COVID-19 demonstrated favorable pregnancy and infection outcomes, according to data published in The Journal of Rheumatology.

The study included 39 pregnant patients — among whom 22 had obstetric data available — with rheumatoid arthritis, systemic lupus erythematosus, psoriatic or other inflammatory arthritides, or antiphospholipid syndrome. The age range of the included patients was 24 to 45 years.

According to the researchers, among the included patients with available obstetric data, 16 experienced term birth. Among the remaining, there were three pre-term births, one termination, one miscarriage, and one patient who had yet to deliver at the time of the researchers’ report. Among the 39 included pregnant patients, 10 were hospitalized following COVID-19 diagnosis, and two required supplemental oxygen. No patients died. In addition, 32 out of the 39 did not receive any specific medication treatment for COVID-19. The remaining seven patients received a combination of antimalarials, colchicine, anti-IL-1-beta, azithromycin, glucocorticoids, and lopinavir/ritonavir.